Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB24FR8FW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,095
Award facts
- Contract value 100% obligated
- $3,094.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes, a medication primarily used to treat asthma and chronic idiopathic urticaria. The delivery order has a ceiling value of $3,094.80 and a period of performance through October 18, 2024.
DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.
Through this vehicle and other prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB24FR8FW?
SPE2DB24FR8FW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2024.
How much is contract SPE2DB24FR8FW worth?
The government has obligated $3,095 on SPE2DB24FR8FW.
Is contract SPE2DB24FR8FW an order under another contract?
Yes. SPE2DB24FR8FW is a delivery order under SPE2DB22D9225, an indefinite delivery contract.
Was contract SPE2DB24FR8FW competed?
The extent of competition for SPE2DB24FR8FW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award